Stryker received FDA 510(k) clearance for its OptaBlate system, and Medtronic received clearance for OsteoCool 2.0.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Stryker Corporation →

  American medical technologies company

  • Norges Bank bought a new position in Stryker Corporation shares, while Vanguard lessened its existing holding.Mon 02:09
  • Medtronic is ramping up its Hugo RAS system to compete with Intuitive Surgical, while its neuroscience unit faces competitive pressure from Stryker and Globus Medical.Sun 14:58
• Medtronic plc →

  medical device company

  • Wolfe Research upgraded Medtronic's stock rating on July 4, 2025, coinciding with the company announcing the integration of the Affera platform.Sun 14:50

Related events

• FDA granted 510k clearance for the ZEISS CLINIC 360 software solution.Aug 19
• Philips received FDA 510(k) clearance for a sensor.Jul 21
• Spineart and eCential Robotics collaborated on a robotic platform for spine surgery, receiving FDA 510(k) clearance.Aug 26